Trials / Unknown
UnknownNCT01701830
Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease
The Relationship Between Serum Omentin-1 and IL-6 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (estimated)
- Sponsor
- Kocaeli Derince Education and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate whether a low level of serum omentin-1 is associated with carotid atherosclerosis and mediated by inflammation.
Detailed description
Atherosclerotic cardiovascular disease is markedly increased in chronic kidney disease. There are a lot of risk factor, along with conventional risk factors. Serum onemtin-1 is a adipokine and suggested as a new marker for vascular disease.It has some anti-atherogenic properties. Studies investigating serum omentin-1 level have usually conducted in patients with diabetes mellitus.
Conditions
Timeline
- Start date
- 2012-10-01
- Completion
- 2013-05-01
- First posted
- 2012-10-05
- Last updated
- 2012-10-05
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01701830. Inclusion in this directory is not an endorsement.